Targeting RAGE Signaling in Inflammatory Disease

Area of Science:

• Immunology
• Molecular Biology
• Pathology

Background:

• The receptor for advanced glycation end-products (RAGE) is a pattern recognition receptor involved in chronic inflammatory conditions.
• RAGE recognizes various damage-associated molecular patterns (DAMPs) and pathogen-associated molecular patterns (PAMPs).
• RAGE expression is low in normal physiology but increases significantly during chronic inflammation due to ligand accumulation.

Purpose of the Study:

• To investigate the role of RAGE in mediating cellular responses to DAMPs and PAMPs.
• To evaluate the therapeutic potential of blocking RAGE signaling in preclinical models of inflammatory diseases.

Main Methods:

• Utilized cell and animal models to study RAGE signaling pathways.
• Assessed the impact of RAGE inhibition on inflammatory markers and disease progression.

Main Results:

• Blocking RAGE signaling effectively reduced inflammation in experimental models.
• Targeting RAGE demonstrated efficacy in impairing the progression of diabetic vascular complications, cardiovascular disease (CVD), and cancer metastasis.

Conclusions:

• RAGE is a critical mediator of inflammation and disease progression in various chronic conditions.
• Inhibiting RAGE represents a promising therapeutic strategy for inflammatory diseases, diabetic complications, CVD, and cancer.
• Ongoing clinical trials are exploring small-molecule RAGE inhibitors for treating inflammatory diseases.